Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HABIT-II: Home BNP Monitoring in Heart Failure
NCT02351063Terminated
- Sponsor
- Alere Inc.
- Start
- Apr 2014
- Primary completion
- Jul 2014
- Countries
- 6
01
Overview
Open-label, single-arm trial in heart failure (HF), sponsored by Alere Inc. Primary endpoint: B-type natriuretic peptide at 6 months. Started Apr 2014; status: terminated.
02
Conditions
heart failure (HF)
Beyond the preview
Go deeper on NCT02351063.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02351063.